Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02240797 · ClinicalTrials.gov registry record
Kappa Opioid Receptor Imaging in Anorexia
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 7
- Enrollment target
NCT02240797: Clinical Trial study, sponsored by NYU Langone Health.
NCT02240797 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02240797 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to use positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) to understand the brain function of individuals with anorexia nervosa and healthy controls.
Primary Outcome
In this study we are using the KOR radioligand \[11C\]PKAB and PET to investigate group differences in cerebral KOR binding potential in 7 AN-REC and 7 healthy controls (HCs).
Interventions
- OTHER Positron emission tomography (PET) imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-03 |
Why NCT02240797 stopped before completion
NCT02240797 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Positron emission tomography (PET) imaging is the first listed.
NCT02240797 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02240797 about?
NCT02240797 is a clinical study titled "Kappa Opioid Receptor Imaging in Anorexia". The purpose of this study is to use positron emission tomography (PET) imaging and magnetic resonance imaging (MRI) to understand the brain function of individuals with anorexia nervosa and healthy controls.
What is the current status of trial NCT02240797?
This trial is currently terminated. The enrollment target is 7 participants. The study started on 2014-09. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02240797?
The interventions under investigation include: Positron emission tomography (PET) imaging (OTHER).
Who is sponsoring clinical trial NCT02240797?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia